Subepicardial delayed gadolinium enhancement in asymptomatic athletes: Let sleeping dogs lie?

British Journal of Sports Medicine

Volumn 50, Issue 2, 2016, Pages 111-117

  Schnell, Frédéric ^a,b   Claessen, Guido ^b   La Gerche, André ^b,c   Bogaert, Jan ^b   Lentz, Pierre Axel ^a   Claus, Piet ^d   Mabo, Philippe ^a   Carré, François ^a   Heidbuchel, Hein ^e  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ADULT; ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPORT; YOUNG ADULT;

ADULT; ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; CONTRAST MEDIA; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDITIS; SPORTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 84954385353     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2014-094546     Document Type: Article

References (40)

1. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2004;26:516-24.
2. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009;43:631-43.
3. Dvorak J, Grimm K, Schmied C, et al. Development and implementation of a standardized precompetition medical assessment of international elite football players 2006 FIFA World Cup Germany. Clin J Sport Med 2009;19:316-21.
4. Schnell F, Riding N, O'Hanlon R, et al. Recognition and significance of pathological T-wave inversions in athletes. Circulation 2015;131:165-73.
5. La Gerche A, Baggish AL, Knuuti J, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging 2013;6:993-1007.
6. Drezner JA, Sharma S, Wilson MG. Sports cardiology: preventing sudden cardiac death. Br J Sports Med 2014;48:1133.
7. Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrastenhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 2014;130:484-95.
8. Bogaert J, Olivotto I. MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology 2014;273:329-48.
9. Masci PG, Doulaptsis C, Bertella E, et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 2014;7:448-56.
10. Wilson M, O'Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 2011;110:1622-6.
11. La Gerche A, Burns AT, Mooney DJ, et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012;33:998-1006.
12. Breuckmann F, Möhlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 2009;251:50-7.
13. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U. S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52:1990-6.
14. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-79.
15. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the "Seattle Criteria." Br J Sports Med 2013;47:122-4.
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
17. Leurent G, Langella B, Fougerou C, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis 2011;104:161-70.
18. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010;121:2462-508.
19. La Gerche A, Claessen G, Van De Bruaene A, et al. Cardiac magnetic resonance imaging: a new gold standard for ventricular volume quantification during high-intensity exercise. Circ Cardiovasc Imaging 2013;6:329-38.
20. Neskovic AN, Otasevic P. Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use. Cardiovasc Ultrasound 2005;3:3.
21. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 2004;25:1093-9.
22. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003;24:1473-80.
23. Wilson M, O'Hanlon R, Prasad S, et al. Myocardial fibrosis in an veteran endurance athlete. BMJ Case Rep 2009;2009: pii: bcr12.2008.1345.
24. Calabrese F. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003;60:11-25.
25. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779-92.
26. Gleeson M. Immune function in sport and exercise. J Appl Physiol 2007;103:693-9.
27. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009;53:1475-87.
28. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-90.
29. O'Mahony C, Elliott P. Anderson-fabry disease and the heart. Prog Cardiovasc Dis 2010;52:326-35.
30. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left dominant ARVC. J Am Coll Cardiol 2008;52:2175-87.
31. Sen-Chowdhry S, Morgan RD, Chambers JC, et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010;61:233-53.
32. Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000;45:16-23.
33. Payne JR. Cardiac effects of anabolic steroids. Br Heart J 2004;90:473-5.
34. Whyte GP. Clinical significance of cardiac damage and changes in function after exercise. Med Sci Sports Exerc 2008;40:1416-23.
35. Chen Y, Serfass RC, Mackey-Bojack SM, et al. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise. J Appl Physiol 2000;88:1749-55.
36. Poussel M, Djaballah K, Laroppe J, et al. Left ventricle fibrosis associated with nonsustained ventricular tachycardia in an elite athlete: is exercise responsible? A case report. J Athl Train 2012;47:224-7.
37. La Gerche A. Can intense endurance exercise cause myocardial damage and fibrosis? Curr Sports Med Rep 2013;12:63-9.
38. Reyes MP, Ho KL, Smith F, et al. A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis 1981;144:232-6.
39. Wesslén L, Påhlson C, Lindquist O, et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 1996;17:902-10.
40. Walsh NP, Gleeson M, Pyne DB, et al. Position statement. Part two: maintaining immune health. Exerc Immunol Rev 2011;17:64-103.